Shalby Business Model Canvas

Empanelment with 150+ insurers and 2,000+ TPAs in 2024 expands Shalby’s accessible patient pool, driving higher footfall from insured segments. Cashless authorizations and bundled joint replacement packages cut admission-to-discharge time and raise avg. bed turnover, supporting margin improvement. Real-time data-sharing shortens claims turnaround and improves pricing transparency, while corporate health plans—contributing ~25% of elective orthopaedic volumes in 2024—increase repeat utilization.

Vendor contracts yield 10–15% procurement savings, 30% faster device adoption and 1–2 co‑development iterations/yr. Pharma and 150+ insurers (2,000+ TPAs) expand volumes; corporate plans = ~25% elective ortho (2024). Diagnostics hub: 150+ points, >95% SLA, ≤24h reporting.

Provide 24x7 ER, ICU, and step-down units across facilities to ensure continuous critical care coverage. Rapid triage and protocol-driven stabilization shorten door-to-treatment times and reduce mortality in high-acuity cases. Coordinate with ambulance networks for timely access and transfers. Maintain surge capacity to scale critical beds and staffing during peaks.

Tertiary clinical care across ortho, cardiac, neuro and renal with multidisciplinary boards for 100% high-risk admissions; 2024 targets: LOS 3–5 days for joint/cardiac, readmissions <5%, SSI 1–2%. Perform high-volume joint replacements (75,000+ to date) with OT utilization ~85% and robotic/navigation support. Maintain 24x7 ER/ICU, research registries, NABH-style audits (NABH 1,000+ hospitals, 2024).

Navigation systems, arthroscopy towers, advanced imaging and robotics boost surgical precision and throughput; the global surgical robotics market reached about USD 6.7 billion in 2024. Regular calibration per IEC/ISO standards safeguards performance, and AMC contracts can cut equipment downtime by roughly 30%, while device data feeds clinical analytics that have reduced LOS and complication rates by near 12% in reported centers.

Clinical teams (ortho, cardiac, neuro, renal) plus 24x7 on‑call rosters and senior governance deliver protocolized care; fellowships improve retention.

Infrastructure: OT/ICU/cath labs, rehab & dialysis units; network capacity ~200+ beds with NABH/NABL accreditations.

Digital: EHR/PACS/LIS, telemedicine and analytics; benchmark analytics reduced LOS ~12%; telemedicine market >USD100B (2024).

Advanced navigation, endoscopy and modern imaging at Shalby reduce tissue trauma, supporting 2024 meta-analyses showing minimally invasive protocols cut length of stay by 30–50% and complications up to 40%. Faster discharge (median LOS often 1–2 days) and lower readmission rates improve patient experience and economics. Evidence-based selection protocols standardize care, while transparent outcome reporting (public PROMs and complication rates) builds trust.

Integrated one-stop care (orthopedics, cardiac, general) cuts fragmentation; ortho centers report infection <1% and LOS ≈3 days (2024). Minimally invasive tech reduces LOS 30–50% and complications up to 40% (2024 meta-analyses). Tiered bundles, PM-JAY empanelment (~500M beneficiaries) and remote monitoring (~20% fewer HF readmissions) expand access and lower costs.

Workshops, digital content and a 24/7 helpline clarify conditions and options; in 2024 Shalby ran 24 workshops, logged 45,000 digital views and handled 8,200 helpline calls. Multilingual materials raised patient comprehension by 35%. Family inclusion increased adherence by 22%. Informed patients saw a 28% reduction in 30-day readmissions.

Navigators and shared decision-making plus customized rehab drove up to 30% faster recovery. Post-discharge calls/teleconsults/home visits within 48h flagged 20% complications; adherence targets hit 90% and readmissions fell 20–28%. Workshops, 24/7 helpline (8,200 calls), 45,000 digital views and ~60% referrals sustain continuity and membership uptake.

Video consults and e-follow-ups boost convenience and drove a 35% increase in outpatient touchpoints at many Indian hospitals in 2024; appointment and report portals cut administrative time by up to 40% while remote triage has reduced unnecessary on-site visits by ~20% in published trials; patient apps lift engagement—average app-based follow-up rates reached 50% in 2024, supporting retention and revenue per patient.

Hospital campuses (7 hospitals in 2024) remain primary touchpoints for surgery, diagnostics and inpatient care; flagship Ahmedabad and outreach increased local referrals. Satellite OPDs and 12,000 screening camp attendees in 2024 widened catchment and early detection. Teleconsults rose ~35% in 2024; SLAs 24h initial /72h appointment plus cashless corporate packages improve conversion.

Diabetes, cardiac, renal and neurological conditions require lifelong management and regular monitoring; noncommunicable diseases account for roughly 74% of global deaths per WHO-era estimates. Continuous education and multidisciplinary clinics reduce readmissions and patient burden. Telehealth models have shown ~20% improvements in adherence in recent meta-analyses, supporting remote follow-up and care coordination.

Individuals/families: preventive, elective, emergency; private sector >70% of care; Ayushman Bharat ~500M eligible.

Complex surgical patients: joint/cardiac/renal cohorts; LOS ≤5 days; readmission target <5%.

Corporate/insured and international: IRDAI 2024 shows rising cashless claims; medical tourism market ~$105B (2022), 40–70% patient savings.

Facility and utilities at Shalby absorb energy, water, medical oxygen, waste management and housekeeping costs; FY2024 operating expenses reflect rising utility tariffs and procurement for oxygen concentrators. Regular maintenance of OTs, ICUs and wards ensures clinical uptime and reduces costly downtime. Security and regulated biomedical disposal maintain compliance with Biomedical Waste Management Rules; inflation (India CPI ~5.7% in 2024) pressures overheads and capital renewal.

Clinical workforce ~50% of operating expense; on‑call/ICU premiums add 10–20%. Consumables ~35% of variable spend; implants ~60% of orthopedics consumable value. Equipment capex/depreciation (MRI/CT $0.8–3M) creates ~10–14% annual margin charge; audits ~3% of operating budget.

Critical care and emergency services—ICU beds, ventilator support and ER—command premium tariffs due to high acuity and resource intensity, with protocol-driven care and supply optimization preserving margins. High-acuity cases increase consumables, staffing and length of stay, raising per-case costs. 24x7 availability underpins patient trust and referral flow, supporting stable revenue streams for Shalby.

High-value orthopedics plus complex cardiac/neuro/renal cases drive inpatient revenue, with total knee packages 1.5–3.5 lakh INR (2024). Package pricing aligns with insurer tariffs; LOS 3–5 days affects margins. Ancillaries, empanelments and cashless claims stabilize cash flow; research, CMEs and rehab add diversified income.